TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages

Carcinogenesis

Volumn 32, Issue 12, 2011, Pages 1789-1797

  Banerjee, Sayantan ^a   Halder, Kuntal ^a   Bose, Anamika ^a   Bhattacharya, Parna ^a   Gupta, Gaurav ^a   Karmahapatra, Santanu ^a   Das, Shibali ^a   Chaudhuri, Shubho ^a   Majumdar, Suchandra Bhattacharyya ^a   Majumdar, Subrata ^a  

^a BOSE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 12; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME PHOSPHORYLATION; HISTONE MODIFICATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONES; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 81855173525     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr208     Document Type: Article

References (42)

1. Bremnes,R.M. et al. (2011) The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and nonsmall cell lung cancer. J. Thorac. Oncol., 6, 209-217.
2. Lorusso,G. et al. (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem. Cell Biol., 130, 1091-1103.
3. Bremnes,R.M. et al. (2011) The role of tumor-infiltrating immune cells and Chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J. Thorac. Oncol., 6, 824-833.
4. De Wever,O. et al. (2003) Role of tissue stroma in cancer cell invasion. J. Pathol., 200, 429-447.
5. Whiteside,T.L. (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene, 27, 5904-5912.
6. Mantovani,A. et al. (1992) The origin and function of tumor-associated macrophages. Immunol. Today, 13, 265-270.
7. Ueno,T. et al. (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res., 6, 3282-3289.
8. Elgert,K.D. et al. (1998) Tumor-induced immune dysfunction: the macrophage connection. J. Leukoc. Biol., 64, 275-290.
9. Mantovani,A. et al. (2004) Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer, 40, 1660-1667.
10. Groeneweg,M. et al. (2006) Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. J. Lipid Res., 47, 2259-2267.
11. Varesio,L. et al. (1984) Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res., 44, 4465-4469.
12. Sica,A. et al. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer, 42, 717-727.
13. Sica,A. et al. (2000) Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol., 164, 762-767.
14. Takanami,I. et al. (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology, 57, 138-142.
15. Leek,R.D. et al. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56, 4625-4629.
16. Pollard,J.W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 4, 71-78.
17. Kang,J.C. et al. (2010) Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J. Surg. Oncol., 102, 242-248.
18. Akira,S. et al. (2003) Toll-like receptors and their signaling mechanisms. Scand. J. Infect. Dis., 35, 555-562.
19. Yu,L. et al. (2010) Endogenous toll-like receptor ligands and their biological significance. J. Cell. Mol. Med., 14, 2592-2603.
20. Zhu,J. et al. (2010) Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm., 2010, 781235.
21. Saccani,A. et al. (2006) p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res., 66, 11432-11440.
22. Mathur,R.K. et al. (2004) Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med., 10, 540-544.
23. Xia,C.Q. et al. (2003) Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase. Scand. J. Immunol., 58, 23-32.
24. Tomczak,M.F. et al. (2006) Defective activation of ERK in macrophages lacking the p50/p105 subunit of NF-kappaB is responsible for elevated expression of IL-12 p40 observed after challenge with Helicobacter hepaticus. J. Immunol., 176, 1244-1251.
25. Lucas,M. et al. (2005) ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol., 175, 469-477.
26. Zacharioudaki,V. et al. (2009) Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J. Immunol., 182, 6444-6451.
27. Kobayashi,K. et al. (2002) IRAK-M is a negative regulator of toll-like receptor signaling. Cell, 110, 191-202.
28. Biswas,S.K. et al. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood, 107, 2112-2122.
29. Kortylewski,M. et al. (2009) Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell, 15, 114-123.
30. Duff,M.D. et al. (2007) Analysis of gene expression in the tumor-associated macrophage. J. Surg. Res., 142, 119-128.
31. Fahey,T.J. et al. (1992) Macrophage inflammatory protein 1 modulates macrophage function. J. Immunol., 148, 2764-2769.
32. Majumdar,S. et al. (1993) Protein kinase C isotypes and signal-transduction in human neutrophils: selective substrate specificity of calcium-dependent beta-PKC and novel calcium-independent nPKC. Biochim. Biophys. Acta, 1176, 276-286.
33. Towbin,H. et al. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
34. Liu,H. et al. (2009) LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells. Mol. Cancer, 8, 92.
35. Green,L.C. et al. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
36. Chomezynasky,P. et al. (1987) A single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
37. Sambrook,J. et al. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Standiford,T.J. et al. (2011) TGF-β-induced IRAK-M expression in tumorassociated macrophages regulates lung tumor growth. Oncogene, 30, 2475-2484.
39. Feng,G.J. et al. (1999) Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol., 163, 6403-6412.
40. Loniewski,K.J. et al. (2007) Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages. Mol. Immunol., 44, 3715-3723.
41. Amarante,M.K. et al. (2010) Toll-like receptor 3: involvement with exogenous and endogenous RNA. Int. Rev. Immunol., 29, 557-573.
42. Erridge,C. (2010) Endogenous ligands of TLR2 and TLR4: agonists or assistants? J. Leukoc. Biol., 87, 989-999.